Anti-Girdin (phospho Ser1417) Antibody (A94235)

Name: Anti-Girdin (phospho Ser1417) Antibody
Brand: Antibodies.com
SKU: A94235
Price: 115.0 GBP
Availability: InStock

Enlarge Image

This product is discontinued

Anti-Girdin (phospho Ser1417) Antibody (A94235) has been discontinued and is no longer available.

View all Girdin Antibodies.

Specifications

Name

Anti-Girdin (phospho Ser1417) Antibody

Description

Rabbit polyclonal antibody to Girdin (phospho Ser1417).

Specificity

This antibody detects endogenous levels of Girdin only when phosphorylated at Ser1417.

Applications

IHC, ELISA

Dilutions

WB: 1:500~1:1000, ELISA: 1:10000

Reactivity

Human, Mouse

Immunogen

Synthetic peptide derived from human Girdin around the phosphorylation site of Ser1417 (amino acids 1383-1432).

Host

Rabbit

Clonality

Polyclonal

Isotype

IgG

Conjugate

Unconjugated

Purification

Purified from rabbit serum by antigen affinity chromatography using the immunizing phospho peptide.

Molecular Weight

216kDa

Product Form

Liquid

Formulation

Supplied in Phosphate Buffered Saline (without Mg2+ and Ca2+), pH 7.4, with 150mM NaCl, 0.02% Sodium Azide, and 50% Glycerol.

Storage

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Synonyms

Akt phosphorylation enhancer, APE, CCDC88A, Coiled-coil domain-containing protein 88A, G alpha-interacting vesicle-associated protein, Girders of actin filament, GIV, GRDN, HkRP1, Hook-related protein 1, KIAA1212

Isotype Controls

Suitable Secondaries

See all Anti-Rabbit IgG Secondaries →

Disclaimer

This product is for research use only. It is not intended for diagnostic or therapeutic use.

Scientific Validation DataValidation Data (1)

Enlarge Image

Immunohistochemistry - Anti-Girdin (phospho Ser1417) Antibody (A94235)

Immunohistochemical analysis of paraffin-embedded human breast carcinoma using Anti-Girdin (phospho Ser1417) Antibody. The right hand panel represents a negative control, where the antibody was pre-incubated with the immunising peptide.